| scholarly article | Q13442814 |
| P50 | author | Cun Liu | Q57639366 |
| Changgang Sun | Q90428176 | ||
| Jie Li | Q90951427 | ||
| Xiaoran Ma | Q90951430 | ||
| Huayao Li | Q90951433 | ||
| Jing Zhuang | Q90951436 | ||
| Chundi Gao | Q90951439 | ||
| Chao Zhou | Q90951443 | ||
| Lijuan Liu | Q90951445 | ||
| Kejia Wang | Q90951447 | ||
| P2093 | author name string | Jie Li | |
| Chao Zhou | |||
| Kejia Wang | |||
| Lijuan Liu | |||
| Jing Zhuang | |||
| Cun Liu | |||
| Changgang Sun | |||
| Chundi Gao | |||
| Huayao Li | |||
| Xiaoran Ma | |||
| P2860 | cites work | Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β | Q26745943 |
| Network pharmacology: the next paradigm in drug discovery | Q28297997 | ||
| Growth-inhibitory and apoptosis-inducing effects of tanshinones on hematological malignancy cells and their structure-activity relationship | Q34229249 | ||
| New developments in the chemistry and biology of the bioactive constituents of Tanshen | Q34652663 | ||
| Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent | Q35729725 | ||
| The anti-inflammatory activities of ethanol extract from Dan-Lou prescription in vivo and in vitro | Q35768547 | ||
| Pathogenesis of myelofibrosis with myeloid metaplasia | Q36315447 | ||
| A Network Pharmacology Approach to Explore the Pharmacological Mechanism of Xiaoyao Powder on Anovulatory Infertility | Q37547543 | ||
| Ca(2+) Signalling in Endothelial Progenitor Cells: Friend or Foe? | Q38561600 | ||
| Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations | Q38586919 | ||
| Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma | Q38706677 | ||
| Evaluation of the anti-inflammatory activities of tanshinones isolated from Salvia miltiorrhiza var. alba roots in THP-1 macrophages | Q38770994 | ||
| Cryptotanshinone, a novel tumor angiogenesis inhibitor, destabilizes tumor necrosis factor-α mRNA via decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR. | Q38840543 | ||
| systemsDock: a web server for network pharmacology-based prediction and analysis | Q40774775 | ||
| Activating JAK2 mutants reveal cytokine receptor coupling differences that impact outcomes in myeloproliferative neoplasm | Q41555800 | ||
| Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs | Q42397239 | ||
| Cytotoxic Activities of Tanshinones Against Human Carcinoma Cell Lines | Q46832937 | ||
| Elevated TNF-alpha and LDH without parathormone disturbance is associated with diffuse osteolytic lesions in leukemic transformation of myelofibrosis | Q46919254 | ||
| Predicted molecular targets and pathways for germacrone, curdione, and furanodiene in the treatment of breast cancer using a bioinformatics approach | Q47102370 | ||
| Uncovering the Pharmacological Mechanism of Astragalus Salvia Compound on Pregnancy-Induced Hypertension Syndrome by a Network Pharmacology Approach | Q47141505 | ||
| Danshen attenuates cartilage injuries in osteoarthritis in vivo and in vitro by activating JAK2/STAT3 and AKT pathways | Q47576461 | ||
| Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking | Q47628715 | ||
| Trypsin inhibitor screening in traditional Chinese medicine by using an immobilized enzyme microreactor in capillary and molecular docking study | Q48314184 | ||
| Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis. | Q49196561 | ||
| The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion | Q49633536 | ||
| Antiproliferative activity and apoptosis induction by trijuganone C isolated from the root of Salvia miltiorrhiza Bunge (Danshen). | Q49719650 | ||
| New therapeutic strategies to treat human cancers expressing mutant p53 proteins | Q49962911 | ||
| Myeloproliferative neoplasms: from origins to outcomes. | Q49989025 | ||
| Allogeneic stem-cell transplantation for myelofibrosis. | Q50497802 | ||
| Danshen attenuates osteoarthritis-related cartilage degeneration through inhibition of NF-κB signaling pathway in vivo and in vitro. | Q50916624 | ||
| Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial. | Q51742255 | ||
| Salvia miltiorrhizaBurge (Danshen): A golden herbal medicine in cardiovascular therapeutics. | Q52561276 | ||
| New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update. | Q52593673 | ||
| An Update on JAK Inhibitors. | Q52626085 | ||
| Cryptotanshinone sensitizes antitumor effect of paclitaxel on tongue squamous cell carcinoma growth by inhibiting the JAK/STAT3 signaling pathway. | Q52753981 | ||
| Novel Therapies for Myelofibrosis. | Q52817185 | ||
| Pharmacotherapy of Myelofibrosis. | Q53119304 | ||
| New tanshinone I derivatives S222 and S439 similarly inhibit topoisomerase I/II but reveal different p53-dependency in inducing G2/M arrest and apoptosis. | Q53683397 | ||
| Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2-V617F mouse model of MPN. | Q54296338 | ||
| Cryptotanshinone inhibits IgE‑mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine‑protein kinase phosphorylation in mast cells. | Q54977741 | ||
| Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion. | Q54979332 | ||
| Recent advances in the diagnosis and management of primary myelofibrosis. | Q54980872 | ||
| Elevated expression of the EZH2 gene in CALR-mutated patients with primary myelofibrosis. | Q54981942 | ||
| A Network Pharmacology Approach to Uncover the Multiple Mechanisms of Hedyotis diffusa Willd. on Colorectal Cancer. | Q54990524 | ||
| Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer | Q57174076 | ||
| VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders | Q79908847 | ||
| Dysregulation of VEGF-induced proangiogenic Ca2+ oscillations in primary myelofibrosis-derived endothelial colony-forming cells | Q86367961 | ||
| STAT3 and apoptosis challenges in cancer | Q88758278 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myelofibrosis | Q1752571 |
| pharmacology | Q128406 | ||
| P304 | page(s) | 8363295 | |
| P577 | publication date | 2018-12-05 | |
| P1433 | published in | Evidence-based Complementary and Alternative Medicine | Q5418319 |
| P1476 | title | Exploring the Mechanism of Danshen against Myelofibrosis by Network Pharmacology and Molecular Docking | |
| P478 | volume | 2018 |
| Q92593539 | Based on network pharmacology to explore the molecular mechanisms of astragalus membranaceus for treating T2 diabetes mellitus |
| Q90705503 | Exploring Pharmacological Mechanisms of Xiang Ju Tablets in the Treatment of Allergic Rhinitis via a Network Pharmacology Approach |
| Q89558541 | Identifying Synergistic Mechanisms of Multiple Ingredients in Shuangbai Tablets against Proteinuria by Virtual Screening and a Network Pharmacology Approach |
| Q99557329 | Mechanisms of indigo naturalis on treating ulcerative colitis explored by GEO gene chips combined with network pharmacology and molecular docking |
| Q92997006 | Top-100 Most Cited Publications Concerning Network Pharmacology: A Bibliometric Analysis |
Search more.